C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Senior Manager - Oncology Commercial Learning and Development

Learning & DevelopmentConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$155k - $205.1k

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 3 years of relevant experience in commercial learning and development, sales training, commercial effectiveness, sales, marketing, or a related role within the pharmaceutical or biotechnology industry.
  • Understanding of adult learning principles, instructional design, curriculum development, and performance-based learning.
  • Ability to translate complex scientific, clinical, and commercial information into clear and engaging learning experiences.
  • Experience facilitating and presenting, producing written communications, and managing projects.
  • Ability to manage multiple priorities and independently lead projects from development through execution.
  • Ability to collaborate cross-functionally and influence stakeholders at multiple organizational levels.
  • Experience with learning management systems and digital learning platforms.
  • Experience with pharmaceutical content review and approval systems such as Veeva.
  • Familiarity with customer relationship management platforms and commercial field technologies.
  • Proficiency with Microsoft PowerPoint, Excel, Word, Outlook, and Teams.
  • Familiarity with emerging learning technologies, including artificial intelligence-enabled tools, and interest in applying technology to improve learning effectiveness and efficiency.
  • Ability to adapt to evolving business priorities in a fast-paced, growing organization.

Responsibilities

  • Design, implement, and continuously improve a comprehensive onboarding curriculum for new Oncology Sales Team hires using existing launch training materials.
  • Partner with subject matter experts across functions to develop and execute learning programs and workshops supporting field and business needs.
  • Manage assigned learning initiatives from development through deployment, ensuring timelines, deliverables, and stakeholder needs are met.
  • Manage the Learning Management System to organize and maintain learning content and make it available to different learner cohorts.
  • Manage training materials through review and approval processes, including Veeva workflows, version control, and curriculum maintenance.
  • Partner with field leadership and Regional Field Trainers to identify learning needs, gather field insights, and support ongoing reinforcement.
  • Apply adult learning principles across live, virtual, digital, and self-directed learning formats.
  • Manage external vendors and agency partners, including project scope, timelines, deliverables, and budgets.
  • Support the development of assessments, certifications, and other reinforcement activities to evaluate knowledge and learning effectiveness.
  • Model and promote the company’s principles by collaborating effectively, embracing possibilities, following data, and leading by doing.
  • Provide consultative support to ex-U.S. teams by sharing U.S. launch training experience, best practices, and relevant resources to inform market-specific training programs.

Desired Qualifications

  • An advanced degree is preferred.
  • Experience with ACTO or a similar learning management system is preferred.
  • Experience with learning-authoring tools such as Articulate 360, Rise, or Storyline is preferred.
  • Oncology experience is strongly preferred.
  • Experience designing and delivering learning programs for customer-facing commercial teams.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs